Genevant Sciences
Pete Zorn has served as President and Chief Legal Officer of Genevant Sciences, Inc. since July 2020. Previously, he was Genevant’s Chief Operating Officer. Prior to joining Genevant, Pete was Chief Corporate Officer and General Counsel of Albireo Pharma, General Counsel and Vice President, Communications of Santaris Pharma (acquired by Roche) and Senior Vice President and General Counsel of Targacept and spent several years in the private practice of corporate law. He brings two decades of life sciences experience as a business and legal executive, as well as a track record of company-building corporate development. Pete received his undergraduate degree from Harvard University and holds a law degree from the University of North Carolina at Chapel Hill.
This person is not in any offices
Genevant Sciences
Genevant is a technology-focused nucleic acid delivery company with world-class platforms, the industry’s most robust and expansive lipid nanoparticle (LNP) patent estate and decades of expertise in nucleic acid drug development. They leverage world-class delivery systems and related technologies to bring new medicines to patients who need them. Genevant does this by selectively collaborating with leading pharma and biotech companies and fostering a culture of innovation that allows them to maintain our leadership position in the space.